KHN939

DRUG2 trials

Sponsors

Beijing Kanghong Biological Medicine Co., Ltd.

Conditions

Thyroid Eye Disease

Phase 3

A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease

Not yet recruitingNCT07720648

Beijing Kanghong Biological Medicine Co., Ltd.Thyroid Eye Disease

Start: 2026-08-01End: 2027-06-01Target: 117Updated: 2026-07-23

A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Active Thyroid Eye Disease

Not yet recruitingNCT07720635

Beijing Kanghong Biological Medicine Co., Ltd.Thyroid Eye Disease

Start: 2026-08-01End: 2027-06-01Target: 60Updated: 2026-07-23